174 related articles for article (PubMed ID: 411569)
1. Modifications of 3'-methyl-4-dimethylaminoazobenzene carcinogenesis of rat liver and carcinogen metabolism by portacaval anastomosis.
Ricco JB; Franco D; Morin J; Decloître F; Bismuth H
Cancer Res; 1977 Dec; 37(12):4500-5. PubMed ID: 411569
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Aflatoxin B1 induced liver carcinogenesis by portal diversion in the rat.
Franco D; Morin J; Szekely AM; Bismuth H
Biomedicine; 1981 Oct; 35(5):162-5. PubMed ID: 6172161
[TBL] [Abstract][Full Text] [Related]
3. Dietary influences on the hepatic mixed-function oxidase system in the rat after portacaval anastomosis.
Proia AD; Edwards KD; McNamara DJ; Anderson KE
Gastroenterology; 1984 Apr; 86(4):618-26. PubMed ID: 6698363
[TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
5. Relationship between alpha-fetoprotein positive cells and precancerous lesions in rat liver during 3'-methyl-4-dimethylaminoazobenzene carcinogenesis.
Stratil P; Dolezalová V; Nĕmecek R; Simícková M
Neoplasma; 1979; 26(4):381-91. PubMed ID: 93242
[TBL] [Abstract][Full Text] [Related]
6. Decreased activation of carcinogens in the liver of carcinogen-resistant rats.
Yano M; Higashi T; Kano S; Tateishi N; Kido Y; Mori T; Higashi K; Sakamoto Y
Cancer Res; 1989 Oct; 49(19):5352-7. PubMed ID: 2548720
[TBL] [Abstract][Full Text] [Related]
7. Binding of the azocarcinogen 3'-methyl-p-dimethylaminoazobenzene to cellular components of normal rat liver and azocarcinogen-induced hepatomas.
Carruthers C; Baumler A; Neilson A; Pressman D
Cancer Res; 1975 Dec; 35(12):3798-06. PubMed ID: 172235
[TBL] [Abstract][Full Text] [Related]
8. [Changes in RNA synthesis at early stages of aminoazocancerogenesis].
Mironov NM; Asler VV; Sokolov NA; Zaboĭkin MM; Shapot VS
Biokhimiia; 1975; 40(4):861-8. PubMed ID: 812558
[TBL] [Abstract][Full Text] [Related]
9. Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity.
Lauterburg BH; Sautter V; Preisig R; Bircher J
Gastroenterology; 1976 Aug; 71(2):221-7. PubMed ID: 939381
[TBL] [Abstract][Full Text] [Related]
10. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants.
Yoshimoto F; Masuda S; Higashi T; Nishii T; Takamisawa I; Tateishi N; Sakamoto Y
Cancer Res; 1985 Dec; 45(12 Pt 1):6155-9. PubMed ID: 3933822
[TBL] [Abstract][Full Text] [Related]
11. The effect of portacaval transposition on hepatic cytochrome P-450 in the rat.
Pector JC; Ossenberg FW; Peignoux M; Benhamou JP
Biomedicine; 1975 Jun; 23(5):160-2. PubMed ID: 1191728
[TBL] [Abstract][Full Text] [Related]
12. Effect of Corynebacterium parvum in prevention and reversal of atrophy of the liver following portacaval shunt.
Fisher B; Gebhardt MC; Saffer EA; Fisher ER
Surg Gynecol Obstet; 1979 Aug; 149(2):168-72. PubMed ID: 462347
[TBL] [Abstract][Full Text] [Related]
13. Disruption of circadian locomotor activity in rats after portacaval anastomosis is not gender dependent.
Steindl PE; Gottstein J; Blei AT
Hepatology; 1995 Dec; 22(6):1763-8. PubMed ID: 7489986
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of 3'-methyl-4-dimethylaminoazobenzene, 2-methyl-4-dimethylaminoazobenzene, and 2-acetylaminofluorene on rat liver DNA stability and new synthesis.
Yager JD; Potter VR
Cancer Res; 1975 May; 35(5):1225-34. PubMed ID: 804349
[TBL] [Abstract][Full Text] [Related]
15. [Changes in hepatic blood flow after various types of portal shunt in the rat].
Castaing D; Crestanello F; Morin J; Bismuth H
Gastroenterol Clin Biol; 1983 Apr; 7(4):335-9. PubMed ID: 6873546
[TBL] [Abstract][Full Text] [Related]
16. [Morphological liver changes after portacaval and splenocaval anastomosis in rats].
Schröder R; Holmin T; Ruchti C; Colombo JP; Peheim E
Helv Chir Acta; 1979 May; 46(1-2):235-8. PubMed ID: 468574
[TBL] [Abstract][Full Text] [Related]
17. A series of inhibitors of azo dye hepatocarcinogenesis partially reverse the azo dye-induced decrease in liver RNA/DNA ratio.
Blunck JM; Smith ML; Vorrath EM
Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):255-69. PubMed ID: 6187053
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 3'-methyl-4-dimethylaminoazobenezene-induced hepatocarcinogenesis by portacaval shunt.
Fiala S; Pragani B; Reuber MD
Tumori; 1978 Apr; 64(2):131-42. PubMed ID: 27891
[TBL] [Abstract][Full Text] [Related]
19. Arterialization of the liver after portacaval shunt in the rabbit.
Vassanelli P; Zannini P; Merigliano S; Maruotti RA
Int Surg; 1980; 65(2):151-5. PubMed ID: 7216658
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of hepatocarcinogenesis by sorbitan fatty acid ester, a liver pyruvate kinase activity-reducing substance.
Yanagi S; Sakamoto M; Takahashi S; Hasuike A; Konishi Y; Kumazawa K; Nakano T
J Natl Cancer Inst; 1985 Aug; 75(2):381-4. PubMed ID: 3860690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
